NHBPA ‘Will Not Exploit the Deaths of Horses To Make a Point’

Not even 24 hours after the Horseracing Integrity and Safety Act (HISA) Authority and the Federal Trade Commission (FTC) alleged links between the sport's recent adverse headlines and the National Horsemen's Benevolent and Protective Association (NHBPA)'s request to delay the May 22 implementation of the Anti-Doping and Medication Control (ADMC) program, the NHBPA fired back with a response that stated the fatalities of seven horses during GI Kentucky Derby week shouldn't be used as a means to make legal arguments in the 2-year-old lawsuit.

“The Horsemen will not exploit the deaths of horses to make a point, because this industry is not going to fix anything moving forward by pointing [fingers],” stated the first line of the NHBPA's May 12 filing.

United States District Court Judge James Wesley Hendrix of the Northern District of Texas (Lubbock Division) had given the NHBPA until the close of the court on Monday, May 15, to file a response to the arguments against delaying the ADMC that were articulated May 11 by the HISA Authority and the FTC defendants.

But because the HISA Authority alleged in its Thursday filing that “recent headlines provide fresh reminders” of “inconsistent regulation,” and because the FTC claimed that the NHBPA has “repeatedly challenged” HISA's efforts to “prevent these kinds of tragedies,” the horsemen plaintiffs wasted little time in trying to address those accusations with a legal response by midday Friday, well ahead of the judge's deadline.

The NHBPA's filing stated that the equine fatalities during Derby week did, in effect, occur under the HISA regulatory framework, citing a May 8 statement released by the HISA Authority that said, “Churchill Downs has been cooperating with HISA since its inception and is in full compliance with our rules and processes.”

The NHBPA also stated that it was the FTC itself, and not any legal efforts by the NHBPA, that kept the ADMC from being in place before the Triple Crown series started.

“It was also the FTC's choice to delay the ADMC from May 1 to May 22. The NHBPA did not delay the ADMC rules until after the Kentucky Derby. The Defendants made that choice because in their view the rules were not ready for implementation in prime time on the most important race of the year,” the NHBPA's filing stated.

“[T]he Authority is still caught in its own logic trap as to the ADMC,” the NHBPA filing stated. “On the one hand, they say, 'few substances that were broadly legal under most states' preexisting regulations are prohibited under the new HISA rules.' On the other hand, they say the ADMC must go into effect immediately or horses will die because current state regulations are insufficient.”

On Mar. 15, 2021, the NHBPA and 12 of its affiliates sued the FTC and HISA Authority personnel, seeking to derail HISA's implementation on constitutional grounds. Judge Hendrix dismissed that suit on March 31, 2022.

The NHBPA plaintiffs appealed, leading to a Fifth Circuit Court reversal on Nov. 18, 2022, that remanded the case back to the Lubbock Division. In the interim, an amended version of HISA was signed into law Dec. 29, 2022. That fix was designed to make HISA compliant with the constitutional defects the Fifth Circuit had identified. On May 6, 2023, Hendrix validated the newer version of HISA as constitutional.

Now the NHBPA is planning another appeal back to the Fifth Circuit, and it wants the ADMC's rollout stopped while that process plays out.

The HISA Authority's May 11 filing explained that it sees the overall issue this way: “Congress, the Executive, and both federal courts [have] come to the same correct conclusion: the Act is now constitutional.”

The NHBPA's May 12 filing countered that claim: “Congress did not 'follow the blueprint'–it made the barest tweak possible to keep the law alive and take a second shot at the courts allowing it to go through.”

The post NHBPA ‘Will Not Exploit the Deaths of Horses To Make a Point’ appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Lucinda Finley Q&A: HISA Critics Throwing `Everything” Until Something “Sticks’

After a series of false starts, the Horseracing Integrity and Safety Act's (HISA) signature anti-doping and medication control (ADMC) program is now set to go into effect on May 22.

Continuing to play out against this latest development are a handful of lawsuits seeking to derail the law—a complex legal landscape evolving at seemingly vertigo-inducing speed.

In a ruling delivered last week, judge James Hendrix of the Lubbock Division of the Northern District of Texas found the version of the act amended by Congress at the end of last year to pass constitutional muster. A separate lawsuit filed in the Amarillo Division of the Northern District of Texas had been rolled into this case.

The plaintiffs immediately announced they would appeal the decision, which means the case will go back up to the U.S. Fifth Circuit Court of Appeals.

In a case led by the states of Oklahoma, West Virginia and Louisiana, the U.S. Sixth Circuit Court of Appeals earlier this year also found the version of HISA Congress amended at the end of 2022 to be constitutional. The plaintiffs subsequently petitioned for a rare en banc rehearing of the case. If granted, the hearing would go before all judges within that Court of Appeals.

Another case led by the State of Louisiana is currently before the Lafayette Division of the Western District of Louisiana.

Two new HISA-related lawsuits have also recently been filed, one in the Eighth Circuit led by Bill Walmsley, Jon Moss, and the Horsemen's Benevolent and Protective Association (HBPA) for Iowa.

The other is led by officers of the Thoroughbred Racing Association of Oklahoma, in a suit filed in the Tenth Circuit.

To discuss what these various lawsuits mean for HISA's future both in the near and long term, TDN spoke once again with constitutional and appellate law expert Lucinda Finley, Frank Raichle Professor of Trial and Appellate Advocacy, and director of Appellate Advocacy at the University of Buffalo Law School.

The following has been edited for brevity and for clarity from two separate conversations.

TDN: Judge James Hendrix recently issued a ruling finding the version of HISA amended by Congress at the end of last year to be constitutional. What is the significance of this ruling?

LF: First, it's important to point out that this is the same district judge [Hendrix] who had ruled the previous version of the statute to be constitutional. The Fifth Circuit disagreed, so he was revisiting that in light of the Fifth Circuit decision. He came to the same conclusion as the Sixth Circuit U.S. Court of Appeals that Congress fixed the constitutional problem.

So, the significance of the ruling is that we now have the only two federal courts to thus far consider the constitutionality of the HISA statute after Congress amended it have come to the same conclusion. We've had the three judges of the Sixth Circuit U.S. Court of Appeals and judge Hendrix unanimously agree that Congress cured the constitutional problem when it amended the HISA statute last December. So that's very significant.

Ultimately, it will be up to the U.S. Court of Appeals for the Fifth Circuit to see if they agree.

TDN: You're referring to the plaintiff's immediate response to appeal.

 LF: Yes. Of course, whenever any side loses a case in court, they always say they're going to appeal. But the plaintiffs have already won once before the Fifth Circuit and are, I think, strategically correct in trying again.

Let's see what the Fifth Circuit thinks about whether the congressional changes fix the problem the Fifth Circuit previously identified.

TDN: Do you think they've got strong legal legs in this appeal?

 LF: No, I do not. I think the Sixth Circuit decision is very thorough and well-reasoned.

The Fifth Circuit had found the primary problem to be that the pre-amendment version of the HISA statute did not give the [Federal Trade Commission] FTC the ability to reject or modify proposed rules by the authority. But the newly amended statute clearly says that the FTC can completely abrogate or modify any proposed rule by the authority.

Congress tailored their amendment directly to what the Fifth Circuit said was the problem. So, I think it's unlikely that the Fifth Circuit would say, 'well, we really meant more than what we've said before.'

TDN: Does this ruling have any bearing on the separate case before the Lafayette Division of the Western District of Louisiana, pertaining to the states of Louisiana and West Virginia currently operating outside of HISA's jurisdiction?

LF: Not officially. The opinion of the Texas federal district court is not binding on the Louisiana District Court. But it is an influential precedent, just like the Sixth Circuit decision is an influential president.

Ultimately, the appeal of this new ruling by Judge Hendrix from the Lubbock Division of the Texas Federal District Court to the Fifth Circuit—the Fifth Circuit's decision whether the amended version of HISA is constitutional or not—will be the ruling that affects the injunction against enforcing HISA in West Virginia and Louisiana that the federal district court in Louisiana issued. I know it gets very complicated. 'This court said this. This court said that.'

TDN: Just to be clear, when the Fifth Circuit Court of Appeals rules on the appeal from the Lubbock case, that decision will essentially guide whether the current injunction preventing HISA from being enforced in West Virginia and in Louisiana stays or goes?

LF: Yes. I think legally it would. There would be a couple of little steps officially. They would remand that case and the district court would have decide how the Fifth Circuit ruling affected the previous ruling.

What I'm saying is that what the Fifth Circuit decides about whether the congressional amendments to the HISA statute last December—whether they cured the constitutional problem or not—will be the really significant legal decision here for Texas, West Virginia, Louisiana, Arkansas, Arizona and the states that were involved in the case that Judge Hendrix just ruled on, as well as the case before the Louisiana Federal District Court.

TDN: Texas is still taking the stance that state law bars them from allowing federal jurisdiction of races run in their state. Where does this decision leave Texas?

LF: It leaves them with the same choice they're currently facing. Texas can continue to insist that it will not adopt federal rules and as a consequence lose the right to interstate simulcast wagering, or it can choose to adopt the federal rules and rejoin interstate wagering, which is financially essential to the continuation of horse racing in Texas.

You would surmise that perhaps the Texas Racing Commission's insistence that it couldn't agree to follow HISA's regulations was being taken in a strategic hope that federal courts would ultimately find it unconstitutional, and it could continue to be the sole regulator for racing in Texas. But every court ruling now after the Congressional amendments to HISA is cutting the legs out from under that strategy.

It is looking increasingly less likely that a federal court will find the amended version of HISA to be unconstitutional. So, if the Fifth Circuit agrees that the Congressional amendments cured the constitutional problem, the Texas Racing Commission essentially will be faced with an existential choice.

Do they want to fall on their sword, continue to allow the state authority to determine the rules for racing in Texas without any federal uniform rules? If they fall on that sword, they are basically dooming the economic future of racing in Texas as we've seen with the dramatic decreases in betting handle [because of] Texas tracks being barred from participating in interstate simulcasting wagering.

TDN: More generally, the industry is gearing up for the ADMC program to once again go into effect on May 22. From here on in and given the latest lawsuits filed, how realistic do you think it is that HISA's flagship drug and medication enforcement program could be halted through legal intervention?

LF: We clearly have a strategy by the groups that are opposed to HISA to file as many different court cases as they can in different federal courts around the U.S. in different appellate circuits in the hope that one of them might result in a judge issuing a nationwide injunction to halt HISA and its rules.

In a way, it's 'throw everything you can at a lot of different walls in the hope that something will stick somewhere.'

What would potentially put the medication program in jeopardy is if in one of these newly filed or still pending federal cases, a judge issued a nationwide injunction against HISA which would [apply] not just in the state where the case was filed, and not just for the parties that brought the case, but throughout the entire country. It would say that HISA is unconstitutional and cannot enforce its rules.

If that were to happen, then the legal response of the federal government would be to seek a stay of that injunction first in the circuit court, and then potentially in the U.S. Supreme Court, while the overall litigation and appeals processes are played out.

It's similar to what just happened with Judge [Matthew] Kacsmaryk and his ruling against the abortion pill, mifepristone. He said the FDA approval was ineffective everywhere. When the Fifth Circuit only partially stayed that ruling, the government went immediately to the U.S. Supreme Court to say, 'please put a stay or suspension on the ruling while the appellate process goes into play.' And the Supreme Court did that. A similar strategy would play out with HISA.

It's a very long way of coming around to your question. I think that the longer the medication program goes on in effect, the more it takes hold and the more states and tracks are operating under it, the stronger the government's argument would be to put a stay or suspension on the effectiveness of any court ruling against HISA by saying, 'it is upsetting a regulatory status quo that people are already relying on.'

TDN: What can you tell us about the two new lawsuits filed in the Eighth and Tenth Circuits? 

LF: They essentially raise the same arguments that have been raised in other cases.

They argue that even with the changes to the statute, it still delegates too much rulemaking authority to the private authority—an argument that the Sixth Circuit rejected. They argue that it violates the appointment process for federal officials. But that one is kind of subsumed by the delegation of authority argument. They argue that the enforcement mechanism [is unconstitutional] because people who are not federal judges get to adjudicate disputes. But that's an argument that basically challenges the entire regulatory system.

TDN: What do you make of the plaintiff's request for an “en banc” hearing in the Sixth Circuit case led by the states of Oklahoma, West Virginia and Louisiana?

LF: I assume they assessed the likelihood of the Supreme Court taking the case and said, 'no, there really isn't a conflict with the Fifth Circuit. So why not try to get the entire Sixth Circuit to reconsider the case? And if they do, fine.' You've got a lot more judges to convince. If they don't, then your clock for appealing to the Supreme Court runs afresh. But I don't think it's very likely that the Sixth Circuit will agree to take the case 'en banc.'

TDN: What are the chances one of these cases will still make it to the Supreme Court?

LF: I think the chances are entirely determined by whether the Fifth Circuit disagrees with the Sixth Circuit.

If the Fifth Circuit overruled Judge Hendrix's ruling and says, 'no, we don't think Congress cured the problem,' then you would have a direct conflict with the Sixth Circuit about the constitutional validity of a federal statute. In that situation, I think the Supreme Court would have to take the case.

But if the Fifth Circuit affirms Judge Hendrix's new ruling, you'll have no conflict in the circuit, and I do not think the Supreme Court would intervene and take the case.

TDN: If the Fifth Circuit affirms the constitutionality of HISA, you're saying it's significantly less likely that the Eighth and Tenth Circuits will find it unconstitutional?

 LF: That's correct. I guess what I'm saying is that if the Fifth Circuit affirms Judge Hendrix's new ruling and holds that the congressional amendment fixed the constitutional problem, the legal game is very close to being over for the opponents of HISA.

The post Lucinda Finley Q&A: HISA Critics Throwing `Everything” Until Something “Sticks’ appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Screening Levels, Transparency Among Key Topics Day 2 of HBPA Conference

Scientifically-based screening levels and transparency in how policy is made were among key items addressed in the Kent Stirling Memorial Medication Panel, held during Wednesday's second day of the National Horsemen's Benevolent & Protective Association conference at the Hotel Monteleone.

The National HBPA has long advocated for scientifically-developed screening and threshold levels used to determine if a positive finding is a legitimate rules violation, or if a negligible amount was inadvertently transferred to a horse or by contamination with no pharmacological impact on the animal's performance.

The topic comes to the fore with the Horseracing Integrity & Safety Authority (HISA) taking over control of equine-testing policy and enforcement as early as Mar. 27.

Bringing sensitivity into sharper focus, drug-testing and toxicology expert Dr. Steven Barker–now an Emeritus Professor at Louisiana State University after retiring following years as head of its state equine drug-testing lab–used an example of bufotenine, which can be detected in horses' post-race tests if (among other things) they ate hay with reed canary grass in it, and a flea.

Barker cited three horses in the Mid-Atlantic in whom bufotenine was detected at the extremely low levels of between 34.5 and 56.6 picograms per milliliter in blood and between 731.5 and 1,964.5 picograms/ml in urine. If those sound like big numbers, Barker said to consider that “the weight of a new-born female flea, prior to its first blood meal, is 450 micrograms. The blood volume of a horse is approximately 50,000 milliliters.

“So if a horse has 56 picograms per mil of bufotenine in a sample, the total amount of bufotenine in the entire horse is 2.8 micrograms–which would be 0.62 percent of a female flea,” Barker said. “So you imagine a 500- kilogram animal that has 0.62 of a female flea distributed throughout its entire body, what do you think the drug effect would be? Zero to nothing. And this is the case in a lot of the positives being called now.”

He continued, “…If HISA is going to do its job, these kinds of positives have to be given scientific consideration. Not 'Oh, we found it, we confirmed it, you're guilty.' I've seen that way too much. Are they going to worry about the integrity of the industry, worried about giving the industry a black eye for all these positives? When really the more important thing is the integrity and reputation of trainers, owners and the horses affected.”

Comparing U.S. Horseracing Testing Numbers and Human Sports

Dr. Clara Fenger, a Central Kentucky-based veterinarian and racehorse owner with additional degrees in internal medicine and equine exercise physiology, explained that in 2021, the World Anti Doping Agency reported 0.77% positive tests out of the 241,430 athletes tested worldwide, with 40% of the violations being for illegal anabolic steroids. A very small amount are from inadvertent environmental contamination.

In the United States in 2020, out of 243,627 racehorse tests, only 0.43% were declared post-race positives. Of those, 28 percent were for Class 1 substances, and most of those could reasonably be considered inadvertent environmental transfer, such as with methamphetamine and morphine, she said.

While violations in human sports were down 1.19% from 2013, U.S. horse racing rose to that 0.43% of positive findings from 0.34% in 2013, Fenger said. While that still reflects very few “true” attempts to cheat, in her words, she explained the bump in horse racing is explained by labs using their increased sensitivity to find irrelevant minuscule levels of substances that would not be called positives in human testing.

Fenger said labs that will enter into contracts to do testing for HISA must be able to detect substances down to a specified minimum level, known as Minimum Required Performance Levels (MRPL).

“For substances that reflect actual cheating, this is a great system,” Fenger said. “Because if one lab can find it really, really low, they can share their methods with other laboratories and they can all find it better…But for therapeutic medication, this represents a huge difference in regulations state to state, depending on the laboratory doing the testing.”

Underscoring the point of cross contamination, equine pharmacology and toxicology expert at the University of Kentucky's Gluck Equine Research Center Dr. Thomas Tobin offered examples of minute levels of substances transferring to a horse without direct administration.

One came amid a rash of positive findings for the seizure and shingles drug Gabapentin in Ohio, which has an “in-house” screening level of eight nanograms (parts per billion) per millimeter of plasma, Tobin said. The finding of 89.4 ng/ml in a horse's post-race test was traced to the groom, who had a prescription for Gabapentin and urinated in the horse's stall.

In another case, it was a dog urinating in the stall.

“It's now official in the published domain that you can dose a dog with Gabapentin and it can turn up in a racehorse,” Tobin said.

Alluding to Tobin and Barker noting their research benefits from data acquired through open-records requests, former active-duty judge advocate with the U.S. Marine Corps and El Paso attorney Daniel Marquez countered, “That's accountability, that's transparency. With the addition, the inclusion of private entities into the HISA rule-making and policy adoption, we threaten that accountability, that transparency.”

“With HISA and the reliance on individual labs, some of which are private, we lose part of that arm of accountability. Private labs are not subject to those (Freedom of Information Act) laws or state open-record laws.”

To view the full release from Wednesday's session, click here.

The post Screening Levels, Transparency Among Key Topics Day 2 of HBPA Conference appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

HBPA Plaintiffs Tell Fifth Circuit New Law ‘Does Not Fix’ HISA’s Problems

As the Fifth Circuit United States Court of Appeals weighs a motion by the Horseracing Integrity and Safety Act (HISA) Authority to vacate its recent opinion that HISA is unconstitutional, a plaintiff team led by the National Horsemen's Benevolent and Protective Association (NHBPA) on Friday urged the court not to do that, arguing that a new federal law passed two weeks ago to amend the operative language of HISA “does not fix” three alleged constitutionality issues.

“This Court's opinion identified three distinct problems with HISA: 'An agency does not have meaningful oversight if it does not write the rules, cannot change them, and cannot second-guess their substance,'” the NHBPA and its co-plaintiffs wrote in a Jan. 13 response.

“Congress's recent tweak to HISA fails to fix the second problem and does nothing to address the first problem or the third,” the filing continued.

“Under the amended HISA the Federal Trade Commission (FTC) still cannot initiate new rules and still cannot second-guess their substance beyond 'consistency review.' And though it can now modify promulgated rules, the Authority's rules will govern for a while even if the FTC eventually changes them,” the response stated.

“In addition, the amendment reduces the FTC's oversight by eliminating the commission's power to issue interim final rules [and] ultimately, the overall purpose of HISA remains to delegate legislative power to a private corporation to 'develop and implement' programs to regulate the horseracing industry,” the filing stated.

“The prior [Fifth Circuit] opinion was a correct statement of the law and the facts at the time it was issued, and the Authority has not borne its substantial burden to show the 'extraordinary remedy' of vacatur is equitable in this instance,” the response stated.

The underlying lawsuit was initiated by the NHBPA and 12 of its affiliates against personnel from the HISA Authority and the FTC on Mar. 15, 2021, bringing anti-constitutionality claims under the private-nondelegation doctrine, public nondelegation doctrine, Appointments Clause, and the Due Process Clause.

On Mar. 31, 2022, a U.S. District Court judge dismissed that suit, writing in an order that “despite its novelty, [HISA] as constructed stays within current constitutional limitations as defined by the Supreme Court and the Fifth Circuit.”

The HBPA plaintiffs appealed that decision, leading to the Fifth Circuit's reversal on Nov. 18.

But by amending HISA and passing it into law as part of a much broader year-end spending bill, the HISA Authority argued in its Jan. 3, 2023, “motion to vacate” that Congress and the President have done their parts to clear up any lingering constitutional ambiguity, and now the Fifth Circuit is obliged to do its duty to “say what the law is” with regard to the rewritten HISA.

Also on Jan. 13, the state of Texas and its racing commission (both of which had been allowed to join the plaintiffs as “intervenors” with an interest in the outcome), filed a separate response to the HISA Authority's motion to vacate.

“This Court should deny the Authority's motion,” the Texas plaintiffs stated. “Because the Authority tellingly does not assert that Congress's amendment moots this lawsuit…immediate vacatur is not warranted. Instead, as this Court has already remanded the case for further proceedings in the district court, this Court likely should follow its ordinary practice, issue its mandate, and allow the district court to consider the HISA amendment's impact on the merits of this suit in the first instance.”

The post HBPA Plaintiffs Tell Fifth Circuit New Law ‘Does Not Fix’ HISA’s Problems appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights